Karol Franciszek Lubarski

Mr. Karol Franciszek Lubarski

Poznan University of Medical Sciences, Poznań, Wielkopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
MFMagdalena Figlerowicz
Magdalena Figlerowicz
AMAnna Mania
Anna Mania
Karol Franciszek LubarskiKarol Franciszek Lubarski
Karol Franciszek Lubarski
ZLZuzanna Lewandowska
Zuzanna Lewandowska
WSWojciech Służewski
Wojciech Służewski
KMKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska

1 February 2018 in Croatian Medical Journal
Verified
Journal Article
Open access
JNJan Nowak
Jan Nowak
Karol Franciszek LubarskiKarol Franciszek Lubarski
Karol Franciszek Lubarski
LKLukasz M. Kowalik
Lukasz M. Kowalik
JWJaroslaw Walkowiak
Jaroslaw Walkowiak
To investigate the contribution of selected types of articles to h-indices of medical researchers.We used the Web of Science to export the publication records of various members from 26 scientific medical societies (13 European, 13 North American) associated ...

1 March 2021 in Journal of Infection and Public Health
Verified
Journal Article
Open access
Anna ManiaAnna Mania
Anna Mania
KMKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
Karol Franciszek LubarskiKarol Franciszek Lubarski
Karol Franciszek Lubarski
JKJadwiga Kuczma-Napierała
Jadwiga Kuczma-Napierała
JMJustyna Mazurek
Justyna Mazurek
MFMagdalena Figlerowicz
Magdalena Figlerowicz
Children account for a relatively small proportion of laboratory-confirmed SARS-CoV-2 infections. In children, COVID-19 usually has a relatively mild course. However, in rare cases, severe disorders can be observed, and clinical manifestations may differ from adults. The aim of this study is to analyse the frequency, clinical picture and outcome of COVID-19 in children based on the experience from the tertiary care centre and regional sanitary-epidemiological office. We report a study regarding 106 cases of confirmed SARS-CoV-2 infection cases in PCR from a nasopharyngeal swab (age range 1-month – 17-years). In all cases, history was taken. In children who required hospital admission, physical examination and laboratory test were performed according to clinical indications. Twelve of the patients required admission to the hospital. The most common symptoms were anosmia and dysgeusia (75%) and headaches (49%) in outpatients and fever in hospitalised children (75%). Three children from the hospitalised group developed a severe course with increased inflammatory indexes. The clinical picture was more severe in younger children from the hospitalised group. Treatment options were regarded individually in all cases. Our study is the first tour knowledge regarding the clinical course of COVID-19 in Polish children. In general, the clinical course of COVID-19 was mild with anosmia and dysgeusia as the most common symptoms. However, in hospitalised children, a severe progression of the disease and less typical signs as aplastic anaemia may be developed.

25 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Anna ManiaAnna Mania
Anna Mania
KFKamil Faltin
Kamil Faltin
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
PMPaweł Małecki
Paweł Małecki
KJKatarzyna Jonczyk-Potoczna
Katarzyna Jonczyk-Potoczna
MFMagdalena Figlerowicz
Magdalena Figlerowicz
Children with COVID-19 develop moderate symptoms in most cases. Thus, a proportion of children requires hospital admission. The study aimed to assess the history, clinical and laboratory parameters in children with COVID-19 concerning the severity of respiratory symptoms. The study included 332 children (median age 57 months) with COVID-19. History data, clinical findings, laboratory parameters, treatment, and outcome, were evaluated. Children were compared in the groups that varied in the severity of symptoms of respiratory tract involvement. Children who required oxygen therapy represented 8.73%, and intensive care 1.5% of the whole cohort. Comorbidities were present in 126 patients (37.95%). Factors increasing the risk of oxygen therapy included comorbidities (odds ratio (OR) = 92.39; 95% confidence interval (95% CI) = (4.19; 2036.90); p < 0.00001), dyspnea (OR = 45.81; 95% CI (4.05; 518.21); p < 0.00001), auscultation abnormalities (OR = 34.33; 95% CI (2.59; 454.64); p < 0.00001). Lactate dehydrogenase (LDH) > 280 IU/L and creatinine kinase > 192 IU/L were parameters with a good area under the curve (0.804-LDH) and a positive predictive value (42.9%-CK). The clinical course of COVID-19 was mild to moderate in most patients. Children with comorbidities, dyspnea, or abnormalities on auscultation are at risk of oxygen therapy. Laboratory parameters potentially useful in patients evaluated for the severe course are LDH > 200 IU/L and CK > 192 IU/L.

29 April 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Karol Franciszek LubarskiKarol Franciszek Lubarski
Karol Franciszek Lubarski
Anna ManiaAnna Mania
Anna Mania
SMSlawomir Michalak
Slawomir Michalak
KOKrystyna Osztynowicz
Krystyna Osztynowicz
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
MFMagdalena Figlerowicz
Magdalena Figlerowicz
Neurological autoimmune diseases have various origins and pathogeneses. Specific antibodies are associated with paraneoplastic syndromes, other infectious agents, or inherited disorders. We aim to evaluate the relation between the autoantibodies, the chosen symptoms, demographic characteristics, and infection history. We retrospectively analysed 508 children during neurological diagnostics. We investigated serum antineuronal, IgG, IgM anti-ganglioside, and anti-aquaporin-4 in both the serum and cerebrospinal fluid (CSF) anti-cell surface and anti-synaptic protein antibodies in 463, 99, 44, 343, and 119 patients, respectively. The CSF polymerase chain reaction detection of Herpesviridae, enterovirus, B19 parvovirus, adenovirus, and parechovirus involved 261 patients. We included available clinical information and electroencephalographic, radiologic, and microbiological results. The IgM anti-ganglioside antibodies increased the risk of tics and positive symptoms (p = 0.0345, p = 0.0263, respectively), the anti-glutamic acid decarboxylase particle of paresis (p = 0.0074), and anti-neuroendothelium of mutism (p = 0.0361). Anti-neuroendothelium, IgM anti-ganglioside, and CSF anti-N-methyl-D-aspartate antibodies were more often associated with consciousness loss (p = 0.0496, p = 0.0044, p = 0.0463, respectively). Anti-myelin antibodies co-occured with Herpes simplex virus (HSV)-2 IgG (p = 0.0415), anti-CV2 with HSV-1 IgM (p = 0.0394), whereas anti-glial fibrillary acidic protein was linked with past Epstein-Barr virus infection. The anti-ganglioside IgM and anti-myelin particles were bilaterally correlated (p = 0.0472). The clinical pictures may overlap, requiring specialistic diagnostics. We noticed the links between the infection aetiology and the specific autoantibody’s positivity.

19 June 2022 in Journal of Child Neurology
Verified
Journal Article
Closed access
Karol Franciszek LubarskiKarol Franciszek Lubarski
Karol Franciszek Lubarski
Anna ManiaAnna Mania
Anna Mania
PMPaweł Małecki
Paweł Małecki
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
MFMagdalena Figlerowicz
Magdalena Figlerowicz
The identification of central nervous system inflammation etiology leads to adjusted therapy. We analyzed the potential inflammatory and neuro-axonal damage markers in children. Our target was to correlate the findings with a disease's course or a sequalae risk and assess their clinical usefulness. The study included 96 children with symptoms of central nervous system inflammation who underwent diagnostics. The research group involved 24 children with autoimmune disorders and 31 with neuroinfection. The control group included patients with both etiologies excluded. We analyzed the results of routine laboratory tests together with chosen serum (neopterin, interleukin [IL]-1β, IL-6) and CSF (metalloproteinase [MMP]-9, S100B protein) markers. In the whole cohort, CSF MMP-9 correlated with CSF cytosis and serum IL-6 and CRP. In the undivided neuroinflammatory group, CSF S100B correlated with serum IL-6 and IgM concentrations. CSF cytosis was associated with CSF MMP-9 and serum neopterin levels. Among the infective patients, IL-6 was linked with increased CSF MMP-9. We conclude that astroglial protein S100B, neopterin, and cytokine concentrations may enable predicting long-term consequences, whereas CSF MMP-9 concentration may reflect the actual central nervous system injury regardless of etiology.